DBVT Q4 2023 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+780.6% YoY

Gross Profit

$9M100.0% margin

Operating Income

-$12M-134.3% margin

Net Income

-$11M-126.0% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$183M

Total Liabilities

$43M

Stockholders' Equity

$140M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	-$1M	+780.6%
Gross Profit	$9M	-$1M	+780.6%
Operating Income	-$12M	-$38M	+68.6%
Net Income	-$11M	-$39M	+71.5%